Crescent Pharma Limited, based in the United Kingdom, is a fast-growing and independent generic pharmaceutical company. Established in 2003, Crescent Pharma has experienced rapid but sustainable growth and has emerged as a dynamic player in the UK Pharmaceutical industry. With a strong focus on long term robust manufacturing & distribution solutions as well as continuous research & development, Crescent continues to expand our product portfolio and invest in our infrastructure, enabling us to address a wide range of medical conditions and offer cost-effective treatment options for patients. At Crescent Pharma, we are proud of our growth trajectory and remain committed to making a positive impact in the pharmaceutical marketplace.
Crescent Pharma have sites in the following locations Andover, Barnsley, Bolton, Chennai, London and Mablethorpe.
Find out more on our sites page.
If your medication states a month then it should not be used after the last day of the month stated on the packaging. In the example above this would mean April 30th is the last day that the medication can be taken.
The Patient Information Leaflet enclosed in the medicine packaging or the outer packaging itself contains a full list of all the ingredients found in the medicine. Typically, Section 6 of the leaflet provides the ingredient list.
In the event that you do not have the packaging, we advise you to consult either the healthcare professional who prescribed the medication or your pharmacist for assistance.
Our objective with the packaging of Crescent Pharma medicines is to minimize the occurrence of dispensing errors and facilitate patients in correctly identifying their prescribed medication.
The selection of colours, font, layout and overall design aims to mitigate confusion between different medications and various strengths of the same medication. This applies to both patients who consume the treatments and pharmacists responsible for dispensing them.
Extensive research was conducted to develop this packaging style, taking into consideration contrasting colours that prevent similarities among alphabetically listed products or likely prescription combinations when placed adjacent to each other on a pharmacist’s shelf. We also believe that these colours aid in distinguishing between different strengths of the same medication.
The design and materials used in the packaging are registered and licensed by the appropriate authorities.
Crescent Pharma uses a base colour and contrasting coloured circle in order to assist with the differentiation of different medicines and various strengths of the same medicine. Contrasting colours are individually selected in order to prevent potential confusion.
Most of Crescent Pharma’s cartons and patient information leaflets are made from cardboard or paper therefore they are recyclable. For pots, bottles and blisters as these have come into contact with medicine you should check with your pharmacist regarding the most prudent route for safe disposal.
If you believe you have experienced a side effect or an unexpected reaction to a medication (referred to as an adverse event), it is crucial to promptly contact the healthcare professional who prescribed the medicine. They will provide guidance on the necessary steps to take. Additionally, you can consult with your pharmacist for further assistance.
You can also report the side effect to Crescent Pharma by completing this form.
If you have any feedback, comments, or a complaints regarding any of our medications, we kindly request you to reach out to our Customer Services department.
Crescent Pharma sell via approved pharmaceutical wholesalers and pharmacy chains. Pharmacists can order from the wholesales and are able to request a specific medicine if required.
Crescent Pharma are unable to confirm if specific pharmacies are stocking are product.
Crescent Pharma do not supply medicine directly to patients.
Yes. You can request a Crescent Pharma medicine from your pharmacist or doctor. However it remains at the discretion of your healthcare professional to provide the right medicine for their patient.
As a leading distributor in the UK pharmaceutical market, Crescent caters exclusively to appropriately licensed and qualified entities. If you are interested in exploring a business opportunity with Crescent Pharma within the UK, we kindly request that you visit our Customers page for more detail.
Crescent Pharma already work with several key partners across the supply chain and value the strong relationships that we have in place. We are also keen to build our outreach and supplier base. If you are interested in exploring a business opportunity with Crescent Pharma, we kindly request that you visit our Suppliers page for more detail.
There may be information on the Patient Information Leaflet of your medicine that will tell you what you can and cannot take with your medicine. This may include herbal medicines.
In the event that you do not have the packaging, we advise you to consult either the healthcare professional who prescribed the medication or your pharmacist for assistance.
Once a branded medicines patent has expired other Pharmaceutical entities can product their own versions of the previously protected medicine. Generic medicines do not compromise on product quality or efficacy and are subject to the same regulatory standards as their branded counterparts. Generic medicines contain the same active ingredients (key ingredient) as the original branded medicine.
Sometimes the generic version of a medicine may have a different colour, shape or size from the branded equivalent. The active ingredient is the same. These differences do not affect how the medicine works.
Yes. Generic medicines and Branded medicine comply with the same regulatory quality and safety standards. Generic medicines are produced at approved GMP (Good Manufacturing Practice) exactly the same approval required for branded medicine.
Good manufacturing practice (GMP) is the minimum standard that a medicines manufacturer must meet in their production processes. Products must:
• be of consistent high quality
• be appropriate to their intended use
• meet the requirements of the marketing authorisation (MA) or product specification
Good distribution practice (GDP) requires that medicines are obtained from the licensed supply chain and are consistently stored, transported and handled under suitable conditions, as required by the MA or product specification.
Organisations that may have to comply with good manufacturing practice (GMP) and/or good distribution practice (GDP) include:
• manufacturer licence holders
• wholesale dealer licence holders
• blood establishment authorisation holders
• non-UK sites employed by UK MA holders
The Medicines and Health Products Regulatory Agency (MHRA) carries out inspections to check if manufacturing and distribution sites comply with GMP or GDP. Pharmaceutical companies and wholesalers are inspected when they apply for a manufacturer or wholesaler dealer licence and then periodically based on risk assessments. Overseas manufacturing sites are also inspected.
https://www.gov.uk/guidance/good-manufacturing-practice-and-good-distribution-practice
General Sales List ‘GSL’ medicines can be obtained from supermarkets and shops without being dispensed by a licensed pharmacist. Although in some cases there may still be restrictions on the volume that you can purchase.
Pharmacy Only ‘P’ Medicines, are what are referred in the industry as Over The Counter Medicines (OTC) have to be sold under the supervision of a pharmacist.
Prescription Only Medicine ‘POM’, can only be acquired from a licensed Pharmacy with the presentation of a signed and valid prescription from your doctor or qualified healthcare professional.
The Summary of Product Characteristics (SmPC) is a regulatory approved and controlled document that provides the foundation of information for healthcare professionals on how the medicine should be used. The SmPC is regularly updated as more information and data is collected on a product.
Developers of a new pharmaceutical molecule will obtain regulatory approval for a medicine along with a patent for a set amount of years of exclusivity in order to safeguard their invention. Branded medicine is essentially a new medicine under patent.
No. If no generic version of the medicine has been developed by other companies than the originator only the approved version will remain available.
Not always. Sometimes generics may differ in size colour or shape from the branded medicine. However the active ingredient remains the same and has no impact on how the medicine works.
When a new molecule is developed the innovator usually will file a patent to prevent any other company from replicating the drug and to prevent manufacture and sale of the drug. These patents usually last around 20 years but can be extended. The innovator will usually protect their investment as the innovation process can take 10 years plus to develop and gain regulatory approval.
If you have any queries not covered by the FAQs or our website please contact via the contact us page.